We agree with Professor Michael Carrier. The ETHIC Act would help curb Big Pharma’s patent exploitation and bring lower-cost options to market sooner, bringing down drug prices for patients.
Pharmaceutical companies often file duplicative patents on the same drug to make it harder for generic manufacturers to bring competitors to market, reducing options for patients. It’s time to hold Big Pharma accountable and pass the ETHIC Act!